Entry |
|
Symbol |
VEGFA
|
Name |
(RefSeq) vascular endothelial growth factor A
|
KO |
K05448 | vascular endothelial growth factor A |
|
Organism |
aml Ailuropoda melanoleuca (giant panda)
|
Pathway |
aml01521 | EGFR tyrosine kinase inhibitor resistance |
aml04933 | AGE-RAGE signaling pathway in diabetic complications |
aml05163 | Human cytomegalovirus infection |
aml05167 | Kaposi sarcoma-associated herpesvirus infection |
aml05207 | Chemical carcinogenesis - receptor activation |
aml05208 | Chemical carcinogenesis - reactive oxygen species |
aml05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:aml00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100482983 (VEGFA)
04014 Ras signaling pathway
100482983 (VEGFA)
04015 Rap1 signaling pathway
100482983 (VEGFA)
04370 VEGF signaling pathway
100482983 (VEGFA)
04066 HIF-1 signaling pathway
100482983 (VEGFA)
04020 Calcium signaling pathway
100482983 (VEGFA)
04151 PI3K-Akt signaling pathway
100482983 (VEGFA)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04510 Focal adhesion
100482983 (VEGFA)
09150 Organismal Systems
09152 Endocrine system
04926 Relaxin signaling pathway
100482983 (VEGFA)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100482983 (VEGFA)
05206 MicroRNAs in cancer
100482983 (VEGFA)
05205 Proteoglycans in cancer
100482983 (VEGFA)
05207 Chemical carcinogenesis - receptor activation
100482983 (VEGFA)
05208 Chemical carcinogenesis - reactive oxygen species
100482983 (VEGFA)
09162 Cancer: specific types
05212 Pancreatic cancer
100482983 (VEGFA)
05211 Renal cell carcinoma
100482983 (VEGFA)
05219 Bladder cancer
100482983 (VEGFA)
09172 Infectious disease: viral
05163 Human cytomegalovirus infection
100482983 (VEGFA)
05167 Kaposi sarcoma-associated herpesvirus infection
100482983 (VEGFA)
05165 Human papillomavirus infection
100482983 (VEGFA)
09163 Immune disease
05323 Rheumatoid arthritis
100482983 (VEGFA)
09166 Cardiovascular disease
05418 Fluid shear stress and atherosclerosis
100482983 (VEGFA)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
100482983 (VEGFA)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
100482983 (VEGFA)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:aml04052]
100482983 (VEGFA)
00536 Glycosaminoglycan binding proteins [BR:aml00536]
100482983 (VEGFA)
Cytokines and neuropeptides [BR:aml04052]
Cytokines
Growth factors (RTK binding)
100482983 (VEGFA)
Glycosaminoglycan binding proteins [BR:aml00536]
Heparan sulfate / Heparin
Growth factors/receptors
100482983 (VEGFA)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
19:2441374..2456796
|
AA seq |
516 aa
YSFIQGLPSSFFSSAILKSTFFPVLIYFLLPVPRLNRADRLGRLLLYFPKSLRILETSRE
KKEVARAPERSRGRERETGSESARGRASNDRDRGKVSDLLLGVTARARREPSPSGSRSGP
AALTDRQTDTAPRPSAHLLPGRRPRVDAAASRGQEPEPAPAGGVEGVGARGVAVKLFVQL
LGCSRSGGAVVRAGAAEPSGTGRSASSGREEPQSEEGEEEEEKEEERGPRWRLGARKPGS
WTGEAAVCADSAPAARAPQALARASAPGGRGDSLGAEESGPPRSPSRRGSASRAGSGRAS
ETMNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGEHKPHEVVKFMDVYQRSYCRPIETLV
DILQEYPDEVEYIFKPSCVPLMRCAGCCNDEGLECVPTEEFNITMQIMRIKPHQGQHIGE
MSFLQHSKCECRPKKDRARQEKKSIGGKGKGQKRKRKKSRYKPWSVPCGPCSERRKHLFV
QDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR |
NT seq |
1551 nt +upstreamnt +downstreamnt
tattcatttatccagggtttaccctcctcctttttttcttcagcaattttaaaatccaca
ttctttcccgttttaatttattttttgcttcccgttccccgcttaaatcgggccgaccgt
ttggggagattgctcctttacttccccaaatcacttcggattttggaaaccagcagagag
aagaaagaggtagcaagagctccagagagaagtcgaggaagagagagagagacggggtca
gagagcgcgcgcgggcgagcgagcaacgacagggacaggggcaaagtgagtgacctgctt
ttgggggtgaccgccagagcgcggcgtgagccctccccctcgggatcccgcagcggacca
gcagcgctgacggacagacagacagacaccgccccccgccccagtgcccacctcctcccc
ggccggcggccgagggtggacgcggcggcgagccgcgggcaagagccggagcccgcgcct
gcaggcggagtggagggggtcggggctcgcggcgttgcagtgaaacttttcgtccaactt
ctgggttgttcccgctccggaggagccgtggtccgcgccggggcagccgagccgagcgga
accgggagaagtgctagctcgggccgggaggagccgcagtcggaggagggggaggaggaa
gaagagaaggaagaggagagggggccgcggtggcgactcggcgctcggaagccgggctca
tggacgggtgaggcggctgtgtgcgcagacagtgctccagccgcgcgcgcgccccaggcc
ctggcccgggcctcggctccaggaggaagaggagacagcctaggcgccgaagagagcggg
ccgccccgcagtccgagccggagagggagcgcgagccgcgccggctccggccgggcctcc
gaaaccatgaactttctgctctcttgggtgcattggagccttgccttgctgctctacctc
caccatgccaagtggtcccaggctgcacccatggcagaaggagagcacaaaccccacgaa
gtggtgaagttcatggacgtctaccagcgcagctactgccgtcccatcgagaccctggtg
gacatcctccaggagtaccccgacgaggtcgagtacatcttcaagccgtcctgcgtgccc
ctgatgcggtgtgcgggctgttgtaatgacgagggcctggagtgcgtgcccaccgaggag
ttcaacatcaccatgcagattatgcggatcaaacctcatcaaggccagcacatcggggag
atgagcttcctacagcatagcaaatgtgaatgcagaccaaagaaagatagagcaaggcaa
gaaaaaaaatcaattggaggaaagggaaaggggcaaaaaagaaagcgcaagaaatcccgg
tataaaccctggagcgttccctgtgggccttgctcagagcggagaaagcatttgtttgta
caagatccgcagacctgtaaatgttcctgcaaaaacacagactcgcgttgcaaggcgagg
cagcttgagttaaacgaacgtacttgcagatgtgacaagcccaggcggtga |